摘要
目的探讨母牛分支杆菌菌苗(简称微卡)治疗糖尿病合并肺结核的疗效。方法同期选取40例糖尿病合并肺结核初治患者,随机分为A、B组。A组以常规抗痨治疗(2HRZE/4HR),B组在常规抗痨治疗的基础上加用微卡治疗2月。结果B组结核病灶消散吸收、空洞完全或部分闭合、痰结核菌阴转速度均明显快于A组(P<0.05),且不良反应少见。结论微卡可用作糖尿病合并肺结核的免疫治疗。
Objective To evaluate the effect of Mycobacterium vaccae vaccine (M. vaccae vaccine) to treat- ment outcome of new diabetes complicated with pulmonary tuberculosis cases. Methods 40 cases were divided into A group (20 cases) and B group (20 cases). The cases in two groups were treated by the same chemotherapy regi- men of 2HRZE/4HR,the group B were treated immunotherapy with M. vaccae vaccine for 2 months. Results Compared with group A,the effects on improving of X-ray manifestation and sputum smear-negative conversion rates in group B were better (P〈0. 05). The side effect of M. vaccae vaccine were rare. Conclusion The M. vaccae vaccine was helpful for new diabetes complicated with pulmonary tuberculosis.
出处
《中国微生态学杂志》
CAS
CSCD
2005年第4期294-295,共2页
Chinese Journal of Microecology
关键词
分支杆菌
母牛
糖尿病
结核
肺
免疫治疗
M. vaccae vaccine
Diabetes
Tuberculosis puimonary
Immunotherapy